Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bioavailability of two clodronate formulations

G Lapham1, K Aranko, H Hanhijärvi

  • 1Boehringer Ingelheim Limited, Bracknell, Berkshire.

British Journal of Hospital Medicine
|September 4, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient blood management knowledge and practice among clinicians from seven European university hospitals: a multicentre survey.

Vox sanguinis·2017
Same author

The revision of the European blood directives: A major challenge for transfusion medicine.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2015
Same author

Collection, processing and testing of bone, corneas, umbilical cord blood and haematopoietic stem cells by European Blood Alliance members.

Vox sanguinis·2013
Same author

Association of CFU-Mk with total colony-forming units in thawed cord blood units.

Vox sanguinis·2012
Same author

Effects of psychotropic drugs on digit substitution: comparison of the computerized symbol-digit substitution and traditional digit-symbol substitution tests.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Association of cord blood platelet count and volume with hemoglobin in healthy term infants.

Journal of perinatology : official journal of the California Perinatal Association·2010
Same journal

The autopsy in the 1990s.

British journal of hospital medicine·1999
Same journal

Screening for breast cancer.

British journal of hospital medicine·1999
Same journal

Cost-effective monotherapy of concomitant benign prostatic hyperplasia and hypertension.

British journal of hospital medicine·1999
Same journal

Liposarcoma: a review of current diagnosis and management.

British journal of hospital medicine·1999
Same journal

How to do it in surgery: laparoscopic rectopexy.

British journal of hospital medicine·1999
Same journal

The management of ovarian cancer.

British journal of hospital medicine·1999
See all related articles

Sodium clodronate effectively manages bone complications from cancer metastasis, including lesions, high calcium levels, and pain. Clinical data support a daily dosage range of 1600-3200 mg for treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Bone Metabolism

Background:

  • Skeletal metastasis frequently causes debilitating osteolytic lesions, hypercalcemia, and bone pain.
  • Bisphosphonates are a cornerstone in managing skeletal-related events.

Purpose of the Study:

  • To evaluate the efficacy of sodium clodronate in managing complications of skeletal metastasis.
  • To establish appropriate dosing guidelines for sodium clodronate.

Main Methods:

  • Review of clinical data and biochemical parameters.
  • Analysis of patient outcomes related to osteolytic lesions, hypercalcemia, and bone pain.

Main Results:

  • Sodium clodronate demonstrated significant effectiveness in treating osteolytic lesions.

Related Experiment Videos

  • The drug successfully managed hypercalcemia and reduced bone pain associated with skeletal metastasis.
  • Clinical and biochemical data support a total daily dose range of 1600-3200 mg.

    • Conclusions:

    • Sodium clodronate is an effective therapeutic agent for skeletal complications of metastasis.
    • The established dose range provides a guideline for optimal patient management.